-
Entity
-
Individual
-
Location
-
C/O Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston, MA
-
Summary
-
The estimated net worth of Mark Mallon is at least $6.77M dollars as of March 3, 2022. Mark Mallon is the Chief Executive Officer, Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $6.77M.